$0.44 0.00 (0%)
9/18/2009 4:00 PM

Zila, Inc. (ZILA)

CAPS Rating: No stars

The Company is a specialty pharmaceutical company focused on the prevention and treatment of oral cancer.

Results 1 - 4 of 4

Recs

0
Member Avatar Hollykins (< 20) Submitted: 2/2/2007 5:13:17 PM : Outperform Start Price: $2.21 ZILA Score: -61.72

There is a good chance FDA will approve
Oratest cancer detection product for dental care market this year. There are other larger potential markets that look very promising that could follow along.

Recs

0
Member Avatar ctown86294 (< 20) Submitted: 2/2/2007 1:43:34 PM : Outperform Start Price: $2.26 ZILA Score: -62.08

vizulite

Recs

1
Member Avatar dkoolguy7000 (< 20) Submitted: 9/27/2006 10:20:18 AM : Outperform Start Price: $2.23 ZILA Score: -68.81

Zila has been hit hard the last month with speculation that the management is corrupt only looking to put money in their pockets by selling off the only unit of the business that currently brings in the revenue. However, I am still optimistic that the approval of OraTest will happen in the near future propelling the stock to highs never seen before.

Recs

1
Member Avatar souptonutz (< 20) Submitted: 9/22/2006 6:26:20 AM : Outperform Start Price: $2.24 ZILA Score: -70.10

Oral test product (for cancer) is about to launch. It has this (huge) market pretty much to itself.
And the shares have been beaten down.

Results 1 - 4 of 4

Featured Broker Partners